Lyra Therapeutics Cash Flow Statement (2019-2025) | LYRA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-7.80M	-11.04M	-11.05M	-13.62M	-11.91M	-14.37M	-14.77M	-14.22M	-16.25M	-15.62M	-15.65M	-15.16M	-22.45M	-48.13M	-11.87M	-10.98M	-8.55M	-7.44M	-5.98M	-6.95M
Depreciation and Depletion (Quarter)	0.07M	0.30M	0.40M	0.28M	0.28M	0.30M	0.30M	0.26M	0.28M	-0.02M	-0.07M	0.11M	0.10M	0.20M	0.10M	0.17M	0.10M	0.20M	0.10M	0.06M
Share-based Compensation (Quarter)	0.60M	0.66M	0.73M	0.78M	0.84M	1.11M	1.74M	1.76M	1.61M	1.35M	1.44M	1.48M	2.16M	1.12M	1.49M	1.94M	0.82M	0.91M	0.03M	0.56M
Gains from Sales and Divestitures (Quarter)						0.00M	0.00M		0.01M	0.01M	0.01M	0.01M	0.13M	0.03M	0.03M	0.09M	0.37M	0.02M	0.03M	0.04M
Gains from Investment Securities (Quarter)	0.00M	0.44M	1.85M		0.04M				1.42M	1.98M	0.43M	0.63M	0.39M	7.05M		-13.57M	2.97M		0.07M	0.06M
Asset Writedowns and Impairment (Quarter)										1.59M		0.01M		1.88M		1.76M
Cash from Restructuring (Quarter)															1.73M	-0.51M	-0.31M	-0.55M	-0.43M	0.21M
Non-cash Items (Quarter)	0.67M	0.72M	0.81M	0.92M	0.96M	3.54M	1.25M	0.38M	0.06M	3.09M	2.65M	6.33M	12.87M	1.40M	1.30M					0.05M
Cash from Operations (Quarter)	-7.59M	3.38M	-10.31M	-11.30M	-11.90M	-8.47M	-10.85M	-12.16M	-15.85M	-14.28M	-14.11M	-19.06M	-22.45M	-19.98M	-16.22M	-11.35M	-8.84M	-6.59M	-7.36M	-6.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)									0.73M	0.63M	1.06M	1.09M	0.93M	0.68M	0.40M	0.27M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.30M	0.40M	0.28M	0.28M	0.30M	0.30M	0.26M	0.28M	-0.02M	-0.07M	0.11M	0.10M	0.20M	0.10M	0.17M	0.10M	0.20M	0.10M	0.06M
Change in Working Capital
Change in Account Payables (Quarter)	0.45M	0.29M	0.42M	1.18M	-0.66M	-0.98M	1.47M	-2.24M	3.29M	-0.11M	0.80M	-3.54M	-0.56M	2.38M	-2.59M	-1.11M	-0.45M	-0.04M	-0.12M	0.10M
Change in Accured Expenses (Quarter)	-0.98M	0.96M	0.99M	0.28M	-0.09M	1.29M	1.61M	1.96M	-2.32M	-0.61M	2.30M	2.12M	0.83M	-3.33M	-2.90M	-0.57M	-0.34M	-0.20M	-0.94M	-0.33M
Investing Activities
Capital Expenditures (Quarter)	1.16M	0.62M	-0.74M	2.34M	0.09M	-0.09M	0.13M	0.03M	0.04M	0.07M	-0.11M	0.61M	0.35M	-0.29M	2.33M	-0.06M				0.10M
Change in Acquisitions & Divestments (Quarter)									9.80M	25.00M	28.00M	48.09M	30.53M	50.99M	21.00M	28.07M
Cash from Investing Activities (Quarter)	-1.16M	-0.62M	-0.52M	-1.08M	-0.09M	-0.01M	-0.03M	-64.87M	5.32M	-0.56M	-14.98M	-2.36M	7.86M	36.18M	8.14M	28.13M				-0.10M
Financing Activities
Other financing activities (Quarter)			0.10M	0.00M	0.00M	4.01M	0.24M				0.42M	0.32M	0.17M	0.10M	0.02M				0.37M
Change in Capital Stock
Shares Issued (Quarter)	0.26M	0.33M	0.01M		0.01M				0.00M	0.10M	0.00M		0.00M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.26M	0.18M	-0.08M	-0.00M	0.01M	96.49M	-0.24M		0.00M	47.19M	-0.42M	18.92M	8.64M	-0.09M	-0.02M	-0.00M			-0.37M
Change in Cash (Quarter)	-8.49M	2.94M	-10.91M	-12.38M	-11.99M	88.00M	-11.11M	-77.03M	-10.53M	32.34M	-29.51M	-2.50M	-5.95M	16.11M	-8.11M	16.78M	-8.84M	-1.95M	-7.73M	-6.16M
Free Cash Flow (Quarter)	-8.75M	2.76M	-9.58M	-13.63M	-12.00M	-8.38M	-10.98M	-12.19M	-15.89M	-14.35M	-14.01M	-19.67M	-22.80M	-19.70M	-18.55M	-11.29M	-8.84M	-6.59M	-7.36M	-6.16M
Net Cash Flow (Quarter)	-8.49M	2.94M	-10.91M	-12.38M	-11.99M	88.00M	-11.11M	-77.03M	-10.53M	32.34M	-29.51M	-2.50M	-5.95M	16.11M	-8.11M	16.78M	-8.84M	-6.59M	-7.73M	-6.16M

Research Tools

Developers

Lyra Therapeutics Cash Flow Statement (2019-2025) | LYRA

Research Tools

Developers

Lyra Therapeutics Cash Flow Statement (2019-2025) | LYRA

Create an account

Sign In

Reset Password